In patients with COPD both with or without heart failure, AF episodes rise around the time patients are hospitalized for ...

Complex, nationwide analysis included both social and environmental factors and could inform local and national policy.

Currently, COPD-marketed therapy leaders include GSK’s Trelegy Ellipta, which is set to grow in sales to $2.16bn by 2033.

((SL Advertiser)) New treatment option for those with chronic obstructive pulmonary disease or COPD. To learn more, go to ...

Chronic obstructive pulmonary disease is one of the world’s leading causes of death - more than 300 million live with the ...

For those who have COPD and don’t know where to begin, the My COPD Checklist is your first port of call; one that can point ...

Ted Koppel and his wife, Grace Anne Dorney Koppel — who was told she only had a few years left to live after her 2001 COPD ...

Sure, having a cold or respiratory infection can temporarily make it harder to breathe. But if excessive coughing and ...

Cruises are a great way for travelers with COPD to see the world. Most large cruise lines allow passengers to travel with ...

The chronic obstructive pulmonary disease (COPD) market in the seven major markets (7MM) is set to grow from $11.5 billion in ...

GP practices across Greater Manchester will be testing software designed to improve asthma and COPD care during annual ...

Analysts expect the partners’ first-mover advantage, clinical data and existing presence in lung disease to translate into ...